PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 77 filers reported holding PLIANT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,251,692 | +12.2% | 418,206 | +17.2% | 0.00% | 0.0% |
Q2 2023 | $6,465,760 | +12.3% | 356,830 | +64.8% | 0.00% | 0.0% |
Q1 2023 | $5,759,326 | +72.6% | 216,516 | +25.4% | 0.00% | +100.0% |
Q4 2022 | $3,337,440 | -5.4% | 172,656 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $3,528,000 | +355.8% | 168,878 | +74.9% | 0.00% | – |
Q2 2022 | $774,000 | -33.8% | 96,542 | -42.1% | 0.00% | – |
Q1 2022 | $1,170,000 | -46.5% | 166,777 | +3.0% | 0.00% | -100.0% |
Q4 2021 | $2,187,000 | -18.1% | 161,988 | +2.4% | 0.00% | 0.0% |
Q3 2021 | $2,670,000 | -3.4% | 158,161 | +66.7% | 0.00% | 0.0% |
Q2 2021 | $2,763,000 | -24.9% | 94,879 | +1.5% | 0.00% | 0.0% |
Q1 2021 | $3,679,000 | +153.2% | 93,521 | +46.3% | 0.00% | 0.0% |
Q4 2020 | $1,453,000 | +1.8% | 63,945 | +1.5% | 0.00% | 0.0% |
Q3 2020 | $1,428,000 | – | 63,012 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |